4//SEC Filing
Wong Hing C 4
Accession 0001209191-21-055525
CIK 0001828673other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:44 PM ET
Size
5.4 KB
Accession
0001209191-21-055525
Insider Transaction Report
Form 4
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-09-08+800,000→ 800,000 totalExercise: $4.31Exp: 2031-09-07→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866258
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 5:44 PM ET
- Size
- 5.4 KB